Lichen International (LICN) Liabilities and Shareholders Equity (2021 - 2025)

Lichen International (LICN) has 5 years of Liabilities and Shareholders Equity data on file, last reported at $75.6 million in Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity fell 5.34% year-over-year to $75.6 million in Q4 2025; TTM through Dec 2025 was $295.2 million, a 7.68% increase from a year earlier, with the FY2025 full-year figure at $75.6 million, down 5.34% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $75.6 million, up from $67.2 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for LICN reached as high as $79.8 million in Q4 2024 and fell as low as $42.9 million in Q4 2021.
• Historically, Liabilities and Shareholders Equity has averaged $63.3 million across 5 years, with a median of $66.4 million in 2023.
• Across the five-year window, Liabilities and Shareholders Equity jumped 40.88% in 2023 and fell 7.42% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $42.9 million in 2021, then advanced by 8.34% to $46.5 million in 2022, then soared by 40.88% to $65.5 million in 2023, then advanced by 21.81% to $79.8 million in 2024, then decreased by 5.34% to $75.6 million in 2025.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $75.6 million in Q4 2025, $67.2 million in Q2 2025, and $79.8 million in Q4 2024.